Introducing MTBC (NASDAQ:MTBC), The Stock That Soared 399% In The Last Three Years

We think that it's fair to say that the possibility of finding fantastic multi-year winners is what motivates many investors. But when you hold the right stock for the right time period, the rewards can be truly huge. Take, for example, the MTBC, Inc. (NASDAQ:MTBC) share price, which skyrocketed 399% over three years. In more good news, the share price has risen -3.3% in thirty days.

View our latest analysis for MTBC

Because MTBC is loss-making, we think the market is probably more focussed on revenue and revenue growth, at least for now. Generally speaking, companies without profits are expected to grow revenue every year, and at a good clip. That's because fast revenue growth can be easily extrapolated to forecast profits, often of considerable size.

In the last 3 years MTBC saw its revenue grow at 37% per year. That's much better than most loss-making companies. In light of this attractive revenue growth, it seems somewhat appropriate that the share price has been rocketing, boasting a gain of 71% per year, over the same period. It's always tempting to take profits after a share price gain like that, but high-growth companies like MTBC can sometimes sustain strong growth for many years. In fact, it might be time to put it on your watchlist, if you're not already familiar with the stock.

You can see how earnings and revenue have changed over time in the image below (click on the chart to see the exact values).

NasdaqGM:MTBC Income Statement, December 17th 2019
NasdaqGM:MTBC Income Statement, December 17th 2019

You can see how its balance sheet has strengthened (or weakened) over time in this free interactive graphic.

Advertisement

A Different Perspective

Investors in MTBC had a tough year, with a total loss of 3.5%, against a market gain of about 28%. Even the share prices of good stocks drop sometimes, but we want to see improvements in the fundamental metrics of a business, before getting too interested. Longer term investors wouldn't be so upset, since they would have made 11%, each year, over five years. It could be that the recent sell-off is an opportunity, so it may be worth checking the fundamental data for signs of a long term growth trend. While it is well worth considering the different impacts that market conditions can have on the share price, there are other factors that are even more important. For example, we've discovered 3 warning signs for MTBC which any shareholder or potential investor should be aware of.

We will like MTBC better if we see some big insider buys. While we wait, check out this free list of growing companies with considerable, recent, insider buying.

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on US exchanges.

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned.

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Thank you for reading.

About NasdaqGM:CCLD

CareCloud

A healthcare information technology company, provides technology-enabled business solutions, Software-as-a-Service offerings, and related business services to healthcare providers and hospitals primarily in the United States.

Undervalued with excellent balance sheet.

Advertisement

Weekly Picks

LO
Lou_Basenese
GIFT logo
Lou_Basenese on Giftify ·

Giftify ($GIFT): A Small-Cap Incentives Platform with More ScaleThan Its Valuation Suggests

Fair Value:US$2.564.5% undervalued
62 users have followed this narrative
2 users have commented on this narrative
12 users have liked this narrative
BE
PYPL logo
benjamin_lvieq on PayPal Holdings ·

PayPal: PayPal Doesn't Need to Grow – It Needs to Stop Falling – A Mispriced Cash Machine With a Cannibal Buyback

Fair Value:US$6526.7% undervalued
16 users have followed this narrative
0 users have commented on this narrative
5 users have liked this narrative
JD
CELH logo
JD009 on Celsius Holdings ·

From $5M to $2B: Why the 2024 Crash Was the Best Buying Opportunity in Consumer Stocks

Fair Value:US$55.4346.2% undervalued
5 users have followed this narrative
1 users have commented on this narrative
6 users have liked this narrative
WA
ACN logo
Wavefarer on Accenture ·

High-quality global services company facing an AI-driven valuation reset.

Fair Value:US$30154.0% undervalued
1 users have followed this narrative
0 users have commented on this narrative
1 users have liked this narrative

Updated Narratives

RO
RockeTeller
SVL logo
RockeTeller on Silver Mines ·

Australia’s Largest Undeveloped Silver Project Just Got a Low-Cost Makeover

Fair Value:AU$4.1996.8% undervalued
2 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
VA
Valtersa
1180 logo
Valtersa on Saudi National Bank ·

Projected Fair Value of Saudi National Bank Reaches 52

Fair Value:ر.س5228.2% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
ON
ARREIT logo
Ontological on AmanahRaya Real Estate Investment Trust ·

Income Focused ARREIT

Fair Value:RM 0.21104.8% overvalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

IN
Investingwilly
MA logo
Investingwilly on Mastercard ·

Mastercard: The Best Dividend Stock You're Ignoring

Fair Value:US$75028.3% undervalued
89 users have followed this narrative
1 users have commented on this narrative
9 users have liked this narrative
BL
BlackGoat
CBRS logo
BlackGoat on Cerebras Systems ·

The Wafer Giant Threatening NVIDIA's GPU Hegemony

Fair Value:US$415.5450.8% undervalued
62 users have followed this narrative
3 users have commented on this narrative
11 users have liked this narrative
CE
Ceazar
CNXU logo
Ceazar on Conexeu Sciences ·

This small biotech is developing technology that could potentially change how tissue is rebuilt

Fair Value:US$25.3459.2% undervalued
60 users have followed this narrative
0 users have commented on this narrative
9 users have liked this narrative